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ABSTRACT
A gas chromatography-mass spectrometry method for the analysis of phencyclidine (PCP) in urine was subjected to an interlaboratory study. The collaborative study followed the guidelines provided by the Association of Official Analytical Chemists
International. Ten laboratories participated, analyzing 3 samples of PCP-spiked urine as blind duplicate. The repeatability relative
standard deviation (RSDr) and the reproducibility relative standard deviation (RSDR) were between 2.1%-3.6% and 4.2%-7.3%,
respectively. HORRAT values for the reproducibility showed 0.4-0.7, indicating acceptable precision between laboratories. The
method was thus proposed to be used by the drug-abuse urine testing laboratories in Taiwan.
Key words: phencyclidine, GC-MS, urine, inter-laboratory study

INTRODUCTION
Phencyclidine (PCP) is a synthetic drug which
possesses of anesthetic properties and reportedly used
as a treatment of psychiatric patients in England in the
early 1960’s(1). Because of its high psychological dependence, low to moderate physical dependence, and hallucinogenic effect, PCP was placed in Schedule II under
the Controlled Substances Act by the Drug Enforcement Administration (DEA) in United States and also in
Taiwan. Despite retaining its popularity in the United
States, PCP is apparently not a common drug of abuse in
other countries(1). Two cases of PCP abuse were observed
from emergency visiting in the Veterans General hospital,
Taipei, Taiwan in 2007. PCP is not considered as a routine
screening drug in most of the drug-abuse urine testing
laboratories in Taiwan, therefore, the popularity of abuse
is not determined. A method with good reproducibility
for determination the PCP in urine for drug-abuse urine
testing laboratories of Taiwan seems to be necessary.
The analysis of PCP in urine has been accomplished
with gas chromatography(2,3), gas liquid chromatogra-phy(4),
enzyme-linked immunosorbent assay (ELISA)(5), gas chromatography-mass spectrometry (GC-MS)(6,7), immunoassays and gas chromatography-mass spectro-metry(8) and gas
chromatography/surface ionization organic mass spectrom* Author for correspondence. Tel: +866-3-3283201 ext. 2421;
Fax: +866-3-3280592; E-mail: meichich1224@mail2000.com.tw

etry (GC-SIOMS)(9). Currently, using GC-MS to confirm
the screening of positive urine sample is becoming inevitable(10-13). None of the present methods(6-9) is suitable for
most of the drug abuse urine testing laboratories in Taiwan
concerning the analytical equipment system. A sensitive
and specific GC-MS method with selected ion monitoring
(SIM) data analysis is required for establishing the reference among the testing laboratories in Taiwan. This paper
reports the result of a collaborative study designed to validate a GC-MS method for the determination of the PCP in
urine. The analytical protocol was introduced by the United
Chemical Technologies (Bristol, PA, U.S.A.), with minor
modification for this study.

MATERIALS AND METHODS
I. Reagents and Chemicals
PCP (1 mg/mL in methanol) and PCP-d5 (100 μg/
mL in methanol) were purchased from Cerilliant (Austin,
TX, USA). Methanol, ethyl acetate, 2-propanol (IPA),
glacial acetic acid, H3PO4, NaOH, CH 2Cl 2, K 2HPO4, and
KH 2PO4 were purchased from Merck (Darmstadt, Germany). Sodium acetate trihydrate and NH4OH (14.8 M) were
purchased variously from Riedel-deHaen (Seelze, Germany) and J. T. Baker (New Jersey, USA).
The acetate solution (100 mM, pH = 4.5) was pre-
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pared by adding 2.93 g of sodium acetate trihydrate and
1.62 mL of glacial acetic acid in double deionized water to
reach a final volume of 1 L. Phosphate buffer solution (100
mM, pH = 6.0) was prepared by adding 1.70 g of K 2HPO4
and 12.14 g of KH 2PO4 in double deionized water to reach
a final volume of 1 L and adjusting the pH value to 6.0 ±
0.1 by NaOH (10 N). Phosphoric acid solution (3 M) was
prepared by adding 10.2 mL of H3PO4 (14.7 M) in double
deionized water to reach a final volume of 50 mL.
Individual stock solutions containing 4 μg/mL of
PCP and 1 μg/mL of PCP-d5 in double deionized water
were prepared. Working solution of 400 ng/mL of PCP
was subsequently prepared. A blank urine specimen was
collected from a non-drug user and none of the drug was
detected by GC-MS. The blank human urine was spiked
with PCP at the concentrations of 3.125, 6.25, 12.5, 25,
100, and 200 ng/mL for quantitative comparisons. Other
quality-control samples (12.5, 25, and 50 ng/mL) were
prepared in the same way for precision and recovery evaluation. All of the PCP solutions were kept in the dark at
4°C until analysis.
Ⅱ. Extraction
The analytical protocol was performed on a GC-MS
method with solid-phase extraction as described by United
Chemical Technologies (Bristol, PA, U.S.A.)(14) with slight
modification. The extraction columns were Clean Screen®
CSDAU203 containing 200 mg of sorbent in a 3 mL column
(United Chemical Technologies, Bristol, PA, U.S.A).
Fifty microliters of PCP-d5 (1 μg/mL) and 1 mL of
phosphate buffer solution were added to 1 mL of the urine
samples, calibrators or controls. Phosphoric acid solution
or NH4OH was used to adjust the pH to 6.0 ± 0.5. After
activating the column with 2 mL of methanol, 2 mL of
double deionized water and 1 mL of phosphate buffer
solution at a flow rate of 30 mL/min, the sample solution
was loaded over the cartridge at a flow rate of 1-2 mL/min.
The cartridge was washed subsequently with 2 mL of
double deionized water, 2 mL of acetate solution and 2 mL
of methanol at a flow rate of 18 mL/min. The cartridge
was then dried under a stream of nitrogen gas for 2 min.
Finally, 3 mL of eluent (CH 2Cl 2/IPA/NH4OH, 78/20/2, v/
v/v) at a flow rate of 1-2 mL/min passed through and the
eluent was collected in a vial. The extract was evaporated
to dryness under a gentle stream of nitrogen gas at room
temperature and reconstituted in 50 μL of ethyl acetate.
One microliter aliquot of the solution was injected into the
GC-MS analysis in SIM mode.
Ⅲ. GC-MS Procedures
An Agilent 6890 GC/5973N mass selective detector
system was used to acquire the full-scan and selected ion
monitoring (SIM) mass spectrometric data. A Chrompack
DB-5 capillary column (30 m × 0.25 mm i.d., 0.25 μm film
thickness) was used under the following conditions: split-

less injection; helium flow rate, 0.8-1.2 mL/min; injection
port, 200°C; interface, 280°C; column oven programming:
starting at 70°C and holding for 1 min, increasing to
180°C at 20°C/min, then increasing to 230°C at 35°C/min,
holding for 3 min. Ions selected for PCP were m/z 200, 91,
242; the corresponding ions for PCP-d5 were m/z 205, 96,
246 (quantification ions are underlined).
The total analysis time was 11 min per sample with
a solvent delay of 6.5 min. The transfer line temperature
and MS source temperature were 280°C and 150°C,
respectively. The nominal electron energy was set at 70
eV. Full-scan mass spectra of derivatized analytes and
internal standard were collected in the range of m/z 45550 at a scan rate of 2.94 scan/s.
Ⅳ. Collaborative Study
The procedures for the preparation of solutions and
analyze were written as a form of standard operation
procedure (SOP). Ten drug-abuse urine testing laboratories in Taiwan participated in the collaborative study.
All of the testing laboratories passed their own quality
control and were accredited by the National Bureau of
Controlled Drugs, Department of Health, Executive Yuan,
Taiwan. Each collaborator received a reference standard
of PCP, an internal standard of PCP-d5, and test samples
(15, 25, and 75 ng/mL in duplicates) of PCP-spiked urine.
Concentration of the test samples was unknown to the
collaborators. The collaborators also received a set of
instructions regarding the SOP and a report form for
recording results. They were asked to follow the SOP
to analyze the samples, to describe specific operational
parameters of the instrument system used, and to submit
the report forms along with the chromatograms. Each
laboratory was encouraged to use one’s routine analytical
system (e.g. instrument, injector, and column) and to make
individual judgment in adjusting the operating conditions.
Ⅴ. Statistical Analysis(15)
The statistical terms used are those given by the
Association of Official Analytical Chemists (AOAC international), including (a) repeatability (intra-labor-atory)
standard deviation (Sr), (b) repeatability relative standard deviation (RSD r), (c) reproducibility (inter-laboratory) standard deviation (SR), (d) reproducibility relative
standard deviation (RSDR), and (e) HORRAT values.
The acceptability of reproducibility of the method was
assessed on the basis of HORRAT values. Moreover, the
Cochran and Grubbs tests were used for outliers.
The Cochran test is used to remove the extreme individual values from a set of laboratory values. Grubbs test is
used to remove the laboratories with extreme average. The
maximum outlier rate is 2/9 and a study should maintain
valid data from a minimum of 8 laboratories. HORRAT
value is the ratio of observed RSDR to predicted RSDR
(PRSDR= 2C-0.1505, C is the mean concentration found).
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Table 1. GC-MS systems used by the collaborators
Lab.

Column

Instrument

model

length (m)

diameter (mm)

film (μm)

1

Agilent 6890/5973N

Agilent, J&W DB-5

30

0.25

0.25

2

Agilent 6890N/5973N

Agilent, HP-5MS

15

0.25

0.25

3

Agilent 6890/5973

Agilent, HP-5MS

30

0.25

0.25

4

Agilent 6890/5973

Supeleo, Equity-5

12

0.20

0.33

5

Agilent 6890/5973

Quadrex, UAC-1

15

0.25

0.50

6

Agilent 6890N/5973N

Agilent, J&W DB-5

15

0.25

0.25

7

Finnigan GC/Polaris Q

Chrompack, CP-Sil 8CB-MS

30

0.25

0.25

8

Finnigan GC 8000 top/Voyager

Restek, Rtx-5MS

15

0.25

0.25

9

Agilent 6890N/5973N

Agilent, HP-1

15

0.25

0.25

10

Agilent 6890/5973

Agilent, J&W DB-5 MS

29

0.25

0.25

HORRAT value between 0.5 and 1.5 may be taken to indicate that the performance value for the method corresponds
to good performance. Consistent deviations from the ratio
on the low side (values < 0.5) may indicate unreported averaging or excellent training and experience(16).

Table 2. Laboratory analysis results for the determination of phencyclidine in urine by GC-MS
phencyclidine (ng/mL)
Sample 1

RESULTS AND DISCUSSION
I. Reliability of the Method
The retention time of PCP and the PCP-d5 were 9.89
and 9.87 min, respectively. Standard curve for PCP was
linear over the range of urine assayed (3.125-200 ng/mL).
The correlation coefficient of the standard curve was
1.000. Limit of detection and limit of quantification were
3.125 ng/mL and 6.25 ng/mL, respectively. The recovery
obtained at three triplicate concentration levels was 86.6%.
The intraday and interday variability were determined by analyzing 5 replicate controls prepared in blank
urine spiked at 12.5, 25, and 50 ng/mL on a single day
and once daily for five days for each concentration. The
precision was assessed as both intraday and interday and
expressed in terms of RSD (relative standard deviation).
The accuracy was expressed in terms of DFA (difference
from the actual value). The intraday precision obtained
for PCP was 2.9%, 2.2%, and 3.2%, intraday accuracy
was 3.9%, 2.7%, and 10.5%; interday precision was
2.2%, 4.7%, and 6.0%, and the interday accuracy was
0.9%, 0.8%, and 6.9%. These results demonstrated that
this method was suitable for the quantification of PCP in
urine with satisfactory accuracy and precision.
II. Analytical Apparatus of the Collaborators
Table 1 shows the diversity of instrument systems used

Sample 2

1

16.21

16.73

25.60

2

15.54

15.87

26.18

Sample 3

26.35
26.93
a

74.65

77.21

77.05

70.69

78.67

3

16.71

17.15

25.39

4

15.40

16.08

26.24

26.69

74.79

80.61

5

14.67a

25.28

25.33

70.76

74.02

6

16.28

17.77

26.57

26.99

75.27

69.75

7

15.29

14.79

24.99

24.99

68.99

71.21

8

17.85

18.04

27.98

29.24

82.37

81.57

9

15.60

16.23

26.57

26.30

79.17

80.93

10

14.15

14.24

26.25

27.84

79.23

81.28

8.33a

32.48

a

74.23

a

Cochran outlier. Six samples (3 pairs of blind duplicates) were sent
to each laboratory.

by the collaborators. Other analytical conditions of the
GC-MS system (eg. injection mode, column pressure, gas
flow rate, ionization mode, interface temperature, and electron energy etc.) were similar among the collaborators. All
of the collaborators were able to meet the system suitability
requirements of the method. The results were reported by
the collaborators varied from one to three weeks.
Ⅲ. Outlier Treatment of the Collaborative Study
Table 2 illustrates the results of a collaborative study.
The Cochran and Grubbs tests for outliers were conducted
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Table 3. Inter-laboratory study results for the determination of phencyclidine in urine by GC-MS

a

Sample No.

Added (ng/mL)

Found (ng/mL)

No. of labsa

Sr

SR

RSDr, %

RSDR, %

HORRAT

1

15

16.11 ± 1.13

9 (1)

0.47

1.17

2.9

7.3

0.7

2

25

26.46 ± 1.05

9 (1)

0.56

1.12

2.1

4.2

0.4

3

75

76.12 ± 3.92

10

2.75

4.38

3.6

5.8

0.7

 ach value is the number of laboratories retained after elimination of outlier; each value in parenthesis is the number of laboratories
E
removed as outliers. Sr: repeatibility standard deviation. RSDr: repeatability relative standard deviation. SR: reproducibility standard
deviation. RSDR: reproducibility relative standard deviation.

on the data of 10 laboratories for the 3 duplicate samples.
One Cochran outlier was identified for sample 1 and
sample 2. None Grubbs outlier was found. The outliers
were below 2/9 for all the laboratories and within
acceptable limits of the protocol. Although there are two
laboratories shown deviant results among the others in low
concentration and middle concentration of blind samples,
no questions or any further improvement concerning the
analytical method has been requested from collaborators.
Ⅳ. Repeatability and Inter-laboratories Reproducibility
Table 3 presents Sr, SR , RSD r, RSDR , and HORRAT,
which were calculated based on the result of the
collaborative study, excluding the statistical outliers in
accordance with the precision criteria. The RSD r values
(2.1%-3.6%) were less than the RSDR values (4.2%7.3%). HORRAT was 0.4-0.7, less than 2, indicating an
acceptable precision of method and good performance.

CONCLUSIONS
The collaborative study of the GC-MS method for
the determination of PCP in urine has demonstrated
good inter-laboratory reproducibility. The method was
proposed to be used by the drug-abuse urine testing
laboratories in Taiwan.
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